Product Images Exemestane
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Exemestane NDC 0832-0595 by Upsher-smith Laboratories, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
The given text provides information on the proportion surviving, HR (hazard ratio), and log-rank p-value for Exemestane and Tamoxifen treatments. The treatment was randomized between 213 and 307 participants. The text also shows a graph of the duration of disease-free survival in months. The information is likely a part of a medical or clinical trial report.*
Each tablet contains 25mg of the drug Exemestane, USP. The recommended dosage should be obtained from the package insert for full prescribing information. The drug should be stored at 25°C (77°F) with permitted excursions between 16° to 30°C. The tablets should be dispensed in a light-resistant container with child-resistant closure. This drug is produced by Upsher-Smith Laboratories, LLC located in Maple Grove, MN 55369. This drug is available by prescription only in New Zealand and the label was revised on April 2021.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.